Finding ways to identify and treat sepsis before it becomes critical
Identifying pre-sepsis opportunities for early, targeted intervention - Equipment Supplement
['FUNDING_OTHER'] · KAISER FOUNDATION RESEARCH INSTITUTE · NIH-11096927
This study is looking for ways to spot early signs of sepsis, a serious condition, before people even get to the hospital, so that patients can get better care and potentially save lives.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | KAISER FOUNDATION RESEARCH INSTITUTE (nih funded) |
| Locations | 1 site (Oakland, UNITED STATES) |
| Trial ID | NIH-11096927 on ClinicalTrials.gov |
What this research studies
This research focuses on discovering early signs of sepsis, a life-threatening condition, before patients reach the hospital. By analyzing extensive electronic health records and using advanced machine learning techniques, the team aims to identify patterns that could indicate a risk of sepsis. The goal is to develop new strategies for early intervention that could prevent the condition from worsening. Patients may benefit from improved recognition and treatment options that could save lives.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for sepsis, such as those with infections or chronic health conditions.
Not a fit: Patients who are not at risk for sepsis or those who do not present with any signs of infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of sepsis, significantly reducing mortality rates.
How similar studies have performed: Other research has shown promise in early detection of sepsis using electronic health records and machine learning, indicating that this approach could be effective.
Where this research is happening
Oakland, UNITED STATES
- KAISER FOUNDATION RESEARCH INSTITUTE — Oakland, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIU, VINCENT — KAISER FOUNDATION RESEARCH INSTITUTE
- Study coordinator: LIU, VINCENT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.